XML 17 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 89,093 $ 80,931
Marketable securities 439,528 483,946
Accounts receivable, net 11,813 8,952
Collaboration receivable – related party 2,577 1,539
Collaboration receivable – other 2,033 1,928
Royalty receivable – related party 3,300 2,900
Inventory 9,778 7,331
Prepaid expenses and other current assets 29,152 24,177
Total current assets 587,274 611,704
Marketable securities 84,503 152,929
Operating lease assets 91,440 93,643
Property and equipment, net 33,840 31,472
Financing lease assets 881 993
Other assets 1,800 0
Total assets 799,738 890,741
Current liabilities:    
Accounts payable 18,707 21,896
Accrued expenses 39,631 53,142
Deferred revenue – related party 4,748 10,933
Operating lease liabilities 6,466 6,642
Financing lease liabilities 306 273
Total current liabilities 69,858 92,886
Deferred revenue, net of current portion – related party 0 50,580
Operating lease liabilities, net of current portion 104,010 106,074
Financing lease liabilities, net of current portion 571 673
Total liabilities 174,439 250,213
Stockholders’ equity:    
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at March 31, 2020 and December 31, 2019 0 0
Common stock, $0.001 par value; 125,000,000 shares authorized; 68,789,925 and 68,401,105 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively 69 68
Additional paid-in capital 2,181,517 2,156,363
Accumulated other comprehensive income 74 202
Accumulated deficit (1,556,361) (1,516,105)
Total stockholders’ equity 625,299 640,528
Total liabilities and stockholders’ equity $ 799,738 $ 890,741